2026-04-17 バッファロー大学（UB）
＜関連情報＞
- https://www.buffalo.edu/news/releases/2026/04/equitable-glucose-monitoring.html
- https://www.japha.org/article/S1544-3191(25)00695-8/abstract
恵まれない地域社会における持続血糖モニタリングの障壁に対処する薬剤師の役割 Pharmacist’s role in addressing barriers to continuous glucose monitoring within underserved communities
Christ Ange K. Cellino ∙ En-Ling Chen ∙ Julia Pawelek ∙ Christopher J. Daly ∙ David M. Jacobs ∙ Gina M. Prescott
Journal of the American Pharmacists Association Published:January 4, 2026
DOI:https://doi.org/10.1016/j.japh.2025.103016
Abstract
Continuous glucose monitoring (CGM) has transformed diabetes care by enabling real-time tracking of glucose levels, improving glycemic control, reducing hypoglycemia, and enhancing quality of life. Despite their clinical benefits, CGM adoption remains inequitable, with underserved populations facing barriers such as low digital and health literacy, financial hardship, limited provider engagement, and fragmented healthcare system infrastructure. Pharmacists, trusted and accessible providers embedded within communities, have emerged as key collaborators for CGM use through patient education, data interpretation, and treatment optimization. Evidence from community-based settings demonstrates that pharmacist-led CGM interventions are associated with significant reductions in HbA1c, improvements in time-in-range, and enhanced patient engagement, although studies focusing specifically on underserved populations remain limited. Persistent barriers at patient, provider, and system levels must be addressed to achieve equitable CGM system access, including challenges related to cost, digital access or literacy, language barriers, health care professional training and patient education. By advancing pharmacist-led CGM initiatives tailored to the social and cultural needs of underserved populations, there is an opportunity to reduce disparities in CGM utilization and improve diabetes outcomes. This commentary highlights current evidence, identifies gaps, and issues a call to action for expanding pharmacist-led CGM programs in high need populations as a critical step toward promoting health equity in diabetes management.
